secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001628280-24-046016
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter reclassifies Kidney Care as discontinued operations ahead of sale to Carlyle
--------------------------------------------------------------------------------

- Kidney Care business classified as held-for-sale and discontinued operations as of August 2024.
- Supplemental unaudited historical financials for Q1 2023 through Q2 2024 restated accordingly.
- Transaction with Carlye announced August 12, 2024; closing subject to regulatory approvals.
- Prior period financials will be retroactively adjusted to reflect discontinued operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828024046016/0001628280-24-046016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828024046016/bax-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-046016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer